Replies to post #107793 on Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

Great post. Fully agree! I hope you're right about the date and that we hear something about the outcome in July..

....2015!

[TheHound]

I heard next week thru the grape vine. We shall see.

[Drano]

I don't think management is going to walk out of an FDA meeting saying "we got the go-ahead." I'd think that this will be a discussion of what needs to be done, answer questions from both sides, etc., and then word from the FDA later. I could be wrong.

But, it's GOVERNMENT..... sigh.... so quick action isn't exactly their middle name.

[thefamilyman]

Your enthusiasm reminds me of how I felt near the beginning of April with up-listing "imminent" and several pieces of good news (and the possible addition to the Russell index) coming. I'm not a trader but I was so enthusiastic that I bought some "trading shares" at a little over $3. I foolishly did this even though I was already overweighted with CTIX. (I know. Buying those shares was my mistake and entirely my fault.)

Now I'm still holding those CTIX "traders" while I watch the stock I was originally planning to put that money in rise by 30%. But c'est la vie.

However, this time I'm going curb my enthusiasm until I see whether Super CEO or Clark Kent comes out of that phone booth.

FDA meeting countdown starts now: I'm going to assume it takes place on Wednesday the 24th. Which means 9 trading days to go.

To me, this is the one pivotal event I've been anticipating most this year. Their likely approval of Phase III trial for ABSSSI based on review of highly detailed P2B data will provide validation of the whole defensin mimetic platform. Additionally, will open the door for fast track and priority review. Also, as alluded to by LEO, is a major milestone needed before he is looking to advance into serious partnership talks. Start of P3 will bring $$$ monetization of one of our products closer than ever, more realistic than ever, more probable than ever, and therefore more priced in than ever.

All this should only boost share price, bring us to Nasdaq, bring in institutional investors, and further carry CTIX higher. Positive snowball. Can't wait.
- ericseb2003

[JTORENCE]

ericse the FDA always and I repeat always comes up with needing more info/clarifications from these meetings.
Not to burst anyones bubble but don't expect earth shattering news from this meeting, if it actually takes place as scheduled.. Of course Leo will spin it as the best thing since slice bread, but again that's what his job is..

Not bashing as I am a shareholder with muucho bucks in this puppy, but been there before with these small bio-techs and usually disappointed with the meeting results..

Our time will come...

[MinnieM]

My assumption for meeting is last weekday in June or first week of July. But, I'm hoping you are correct.



In Reply to 'ericseb2003'
FDA meeting countdown starts now: I'm going to assume it takes place on Wednesday the 24th. Which means 9 trading days to go. 

To me, this is the one pivotal event I've been anticipating most this year. The likely FDA approval of a Phase III Brilacidin trial for ABSSSI based on thorough review of the highly detailed P2B data provided by CTIX to the drug regulatory agency will offer the market some serious validation of this molecule's potential, and relatedly, of the whole defensin mimetic platform. 

Additionally, this meeting should very likely open the door for the FDA to grant fast track and priority review. Also, as alluded to by Leo, this major milestone is all that is needed before he is looking to advance into serious partnership talks with big pharma. 

The kick-off of a Phase III trial will bring $$$ monetization of one of our products closer than ever, make that revenue windfall more realistic than ever, bottom-line income more probable than ever, and therefore the market will be more likely to FINALLY price in the MULTI-BILLION potential of Brilacidin after this meeting and subsequent trial commencement SOONER rather than later. 

All these positive developments will only serve to boost share price, therefore qualifying us for Nasdaq uplisting, which will in turn FINALLY open door for institutional investment, which will serve to further carry CTIX higher. It's like tinies snowball that packed together and getting ready to roll it down huge mountain of fresh powder. Only going to get bigger and bigger as it gains positive momentum, and soon CTIX will be an avalanche of success!

[JUST 10-11-12]

if the data is so compelling, as we all tend to agree, I think it will be hard pressed to keep it out of the market, particularly the need for the drug and its applications.

any constructive feedback to offer?

I take Leo as a trustworthy person, along with a number of posters here. meaning: naturally we do not have assess to the data, but, the re-investing of a firm (cannot remember its name right now)is a postivie too. Meaning they must think the potential is great to invest such monies.

Keith